{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:01:02Z","timestamp":1778162462389,"version":"3.51.4"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016M3C7A1914002"],"award-info":[{"award-number":["2016M3C7A1914002"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["26-2017-0030"],"award-info":[{"award-number":["26-2017-0030"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea Brain Research Institute","award":["800-20170122"],"award-info":[{"award-number":["800-20170122"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0195968","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T17:26:01Z","timestamp":1525886761000},"page":"e0195968","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Amelioration of Huntington's disease phenotypes by Beta-Lapachone is associated with increases in Sirt1 expression, CREB phosphorylation and PGC-1\u03b1 deacetylation"],"prefix":"10.1371","volume":"13","author":[{"given":"Mijung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Jun","family":"Ban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Young","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0866-4405","authenticated-orcid":true,"given":"Wooseok","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"Huntingtin and the molecular pathogenesis of Huntington&apos;s disease. Fourth in molecular medicine review series","volume":"5","author":"C Landles","year":"2004","journal-title":"EMBO Rep"},{"key":"ref2","volume":"xvii","author":"MR Hayden","year":"1981"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington&apos;s disease","volume":"4","author":"SE Andrew","year":"1993","journal-title":"Nat Genet"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington&apos;s disease","volume":"4","author":"M Duyao","year":"1993","journal-title":"Nat Genet"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"KL Sugars","year":"2003","journal-title":"Trends Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.phrs.2015.08.002","article-title":"Transcriptional dysregulation in Huntington&apos;s disease: The role of histone deacetylases","volume":"100","author":"S Sharma","year":"2015","journal-title":"Pharmacol Res"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington&apos;s disease are a direct effect of polyglutamines","volume":"5","author":"AV Panov","year":"2002","journal-title":"Nat Neurosci"},{"issue":"7113","key":"ref8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"MT Lin","year":"2006","journal-title":"Nature"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2010.06741.x","article-title":"Nature and cause of mitochondrial dysfunction in Huntington&apos;s disease: focusing on huntingtin and the striatum","volume":"114","author":"JM Oliveira","year":"2010","journal-title":"J Neurochem"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","article-title":"Mitochondria in Huntington&apos;s disease","volume":"1802","author":"M Damiano","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1021\/jm00374a010","article-title":"beta-Lapachone: synthesis of derivatives and activities in tumor models","volume":"27","author":"K Schaffner-Sabba","year":"1984","journal-title":"J Med Chem"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00011-012-0557-0","article-title":"Anti-inflammatory and anti-arthritic activities of 3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione (beta-lapachone)","volume":"62","author":"MM Sitonio","year":"2013","journal-title":"Inflamm Res"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.phymed.2013.08.010","article-title":"beta-Lapachone activity in synergy with conventional antimicrobials against methicillin resistant Staphylococcus aureus strains","volume":"21","author":"L Macedo","year":"2013","journal-title":"Phytomedicine"},{"issue":"30","key":"ref14","doi-asserted-by":"crossref","first-page":"22463","DOI":"10.1016\/S0021-9258(18)41552-9","article-title":"beta-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin","volume":"268","author":"CJ Li","year":"1993","journal-title":"J Biol Chem"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"C931","DOI":"10.1152\/ajpcell.00266.2008","article-title":"In vitro and in vivo wound healing-promoting activities of beta-lapachone","volume":"295","author":"HN Kung","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"issue":"28","key":"ref16","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.1073\/pnas.0702176104","article-title":"An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone","volume":"104","author":"EA Bey","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1073\/pnas.0538044100","article-title":"Selective killing of cancer cells by beta -lapachone: direct checkpoint activation as a strategy against cancer","volume":"100","author":"Y Li","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.intimp.2006.12.006","article-title":"Anti-inflammatory effects of beta-lapachone in lipopolysaccharide-stimulated BV2 microglia","volume":"7","author":"DO Moon","year":"2007","journal-title":"Int Immunopharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12974-015-0355-z","article-title":"beta-Lapachone suppresses neuroinflammation by modulating the expression of cytokines and matrix metalloproteinases in activated microglia","volume":"12","author":"EJ Lee","year":"2015","journal-title":"J Neuroinflammation"},{"issue":"1\u20132","key":"ref20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cbi.2010.10.013","article-title":"beta-Lapachone-induced reactive oxygen species (ROS) generation mediates autophagic cell death in glioma U87 MG cells","volume":"189","author":"EJ Park","year":"2011","journal-title":"Chem Biol Interact"},{"issue":"21","key":"ref21","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1016\/j.bmcl.2015.06.073","article-title":"Mitochondrial targeted beta-lapachone induces mitochondrial dysfunction and catastrophic vacuolization in cancer cells","volume":"25","author":"J Ma","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e1599","DOI":"10.1038\/cddis.2014.564","article-title":"NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by beta-lapachone","volume":"6","author":"Z Moore","year":"2015","journal-title":"Cell Death Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.freeradbiomed.2016.05.024","article-title":"beta-Lapachone increases phase II antioxidant enzyme expression via NQO1-AMPK\/PI3K-Nrf2\/ARE signaling in rat primary astrocytes","volume":"97","author":"JS Park","year":"2016","journal-title":"Free Radic Biol Med"},{"issue":"31","key":"ref24","doi-asserted-by":"crossref","first-page":"21745","DOI":"10.1074\/jbc.M602909200","article-title":"Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction","volume":"281","author":"W Qin","year":"2006","journal-title":"J Biol Chem"},{"key":"ref25","first-page":"404","article-title":"SIRT1: linking adaptive cellular responses to aging-associated changes in organismal physiology","volume":"21","author":"D Anastasiou","year":"2006","journal-title":"Physiology (Bethesda)"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.str.2006.07.004","article-title":"Sirtuins caught in the act","volume":"14","author":"BC Smith","year":"2006","journal-title":"Structure"},{"issue":"13","key":"ref27","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1038\/sj.emboj.7601758","article-title":"SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer&apos;s disease and amyotrophic lateral sclerosis","volume":"26","author":"D Kim","year":"2007","journal-title":"EMBO J"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20070140","article-title":"Sirtuins in mammals: insights into their biological function","volume":"404","author":"S Michan","year":"2007","journal-title":"Biochem J"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molcel.2004.08.031","article-title":"Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin","volume":"16","author":"A Vaquero","year":"2004","journal-title":"Mol Cell"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0092-8674(01)00527-X","article-title":"hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase","volume":"107","author":"H Vaziri","year":"2001","journal-title":"Cell"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0092-8674(04)00126-6","article-title":"Mammalian SIRT1 represses forkhead transcription factors","volume":"116","author":"MC Motta","year":"2004","journal-title":"Cell"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-8674(01)00524-4","article-title":"Negative control of p53 by Sir2alpha promotes cell survival under stress","volume":"107","author":"J Luo","year":"2001","journal-title":"Cell"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nm.2558","article-title":"Neuroprotective role of Sirt1 in mammalian models of Huntington&apos;s disease through activation of multiple Sirt1 targets","volume":"18","author":"M Jiang","year":"2011","journal-title":"Nat Med"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.2559","article-title":"Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway","volume":"18","author":"H Jeong","year":"2011","journal-title":"Nat Med"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K","article-title":"Mitochondrial dysfunction and free radical damage in the Huntington R6\/2 transgenic mouse","volume":"47","author":"SJ Tabrizi","year":"2000","journal-title":"Ann Neurol"},{"issue":"43","key":"ref36","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","article-title":"Expression profiling of Huntington&apos;s disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration","volume":"27","author":"AD Strand","year":"2007","journal-title":"J Neurosci"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2006.10.023","article-title":"PGC-1alpha, a new therapeutic target in Huntington&apos;s disease?","volume":"127","author":"JK McGill","year":"2006","journal-title":"Cell"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/sj.emboj.7601633","article-title":"Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1\/PGC-1alpha","volume":"26","author":"Z Gerhart-Hines","year":"2007","journal-title":"EMBO J"},{"issue":"7029","key":"ref39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature03354","article-title":"Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1","volume":"434","author":"JT Rodgers","year":"2005","journal-title":"Nature"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha","volume":"127","author":"M Lagouge","year":"2006","journal-title":"Cell"},{"issue":"16","key":"ref41","doi-asserted-by":"crossref","first-page":"16456","DOI":"10.1074\/jbc.M501485200","article-title":"SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}","volume":"280","author":"S Nemoto","year":"2005","journal-title":"J Biol Chem"},{"issue":"11","key":"ref42","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1096\/fj.05-5189fje","article-title":"Nitric oxide regulates mitochondrial oxidative stress protection via the transcriptional coactivator PGC-1alpha","volume":"20","author":"S Borniquel","year":"2006","journal-title":"FASEB J"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"J St-Pierre","year":"2006","journal-title":"Cell"},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1073\/pnas.1232352100","article-title":"An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle","volume":"100","author":"C Handschin","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"L Cui","year":"2006","journal-title":"Cell"},{"issue":"142","key":"ref46","doi-asserted-by":"crossref","first-page":"142ra97","DOI":"10.1126\/scitranslmed.3003799","article-title":"PGC-1alpha rescues Huntington&apos;s disease proteotoxicity by preventing oxidative stress and promoting TFEB function","volume":"4","author":"T Tsunemi","year":"2012","journal-title":"Sci Transl Med"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1111\/ejn.13275","article-title":"Exosomes from adipose-derived stem cells ameliorate phenotype of Huntington&apos;s disease in vitro model","volume":"44","author":"M Lee","year":"2016","journal-title":"Eur J Neurosci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"16887","DOI":"10.1038\/srep16887","article-title":"Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington&apos;s disease R6\/2 model","volume":"5","author":"W Im","year":"2015","journal-title":"Sci Rep"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tem.2013.12.001","article-title":"SIRT1 and other sirtuins in metabolism","volume":"25","author":"HC Chang","year":"2014","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"ref50","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2174\/1389450111007011270","article-title":"Sirtuins: common targets in aging and in neurodegeneration","volume":"11","author":"RM de Oliveira","year":"2010","journal-title":"Curr Drug Targets"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nm.2624","article-title":"Finding a sirtuin truth in Huntington&apos;s disease","volume":"18","author":"AR La Spada","year":"2012","journal-title":"Nat Med"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0166-2236(99)01500-3","article-title":"Is CREB a key to neuronal survival?","volume":"23","author":"MR Walton","year":"2000","journal-title":"Trends Neurosci"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng882","article-title":"Disruption of CREB function in brain leads to neurodegeneration","volume":"31","author":"T Mantamadiotis","year":"2002","journal-title":"Nat Genet"},{"issue":"3","key":"ref54","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1172\/JCI27794","article-title":"PGC-1 coactivators: inducible regulators of energy metabolism in health and disease","volume":"116","author":"BN Finck","year":"2006","journal-title":"J Clin Invest"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","article-title":"The energetics of Huntington&apos;s disease","volume":"29","author":"SE Browne","year":"2004","journal-title":"Neurochem Res"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","article-title":"Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice","volume":"119","author":"J Lin","year":"2004","journal-title":"Cell"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington&apos;s disease transgenic mice implicate PGC-1alpha in Huntington&apos;s disease neurodegeneration","volume":"4","author":"P Weydt","year":"2006","journal-title":"Cell Metab"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/AAC.14.4.630","article-title":"Generation of superoxide anions and hydrogen peroxide from beta-lapachone in bacteria","volume":"14","author":"FS Cruz","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ref59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00403-015-1543-5","article-title":"Melanogenesis inhibition of beta-lapachone, a natural product from Tabebuia avellanedae, with effective in vivo lightening potency","volume":"307","author":"JH Kim","year":"2015","journal-title":"Arch Dermatol Res"},{"issue":"10","key":"ref60","doi-asserted-by":"crossref","first-page":"e47122","DOI":"10.1371\/journal.pone.0047122","article-title":"Beta-lapachone, a modulator of NAD metabolism, prevents health declines in aged mice","volume":"7","author":"JS Lee","year":"2012","journal-title":"PLoS One"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2011.02.060","article-title":"Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome","volume":"1394","author":"CJ Alves","year":"2011","journal-title":"Brain Res"},{"issue":"6","key":"ref62","doi-asserted-by":"crossref","first-page":"e64953","DOI":"10.1371\/journal.pone.0064953","article-title":"Pharmacological activation of Sirt1 ameliorates polyglutamine-induced toxicity through the regulation of autophagy","volume":"8","author":"BH Shin","year":"2013","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0195968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T17:04:37Z","timestamp":1720285477000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0195968"}},"subtitle":[],"editor":[{"given":"Kah-Leong","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,9]]},"references-count":62,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0195968","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,9]]}}}